Minimal Symptom Expression and Minimal Manifestations in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (S16.001)
Although most patients with chronic inflammatory demyelinating polyneuropathy (CIDP) respond to immunotherapy, residual neurologic disability is common. The objective of this study is (1) to determine the frequency of minimal symptom expression (MSE) in CIDP and (2) to use that information to develop definitions for minimal manifestations (MM).
Authors
- Jeffrey Allen
- Abhigyan Datta (ORCID: https://orcid.org/0000-0002-2269-546X)
- Stephen C. Ward (ORCID: https://orcid.org/0000-0002-2008-5334)
Institutions
- University of Minnesota System (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212514
- Primary Topic
- Hereditary Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00